References
- Bush NAO, Chang SM, Berger MS. Current and future strategies for treatment of glioma. Neurosurg Rev. 2017;40(1):1–14.
- Khain E, Sander LM, Stein AM. A model for glioma growth. Complexity. 2017;11(2):53–57.
- Yang Y, Gao X, Zhang M, et al. Novel role of FBXW7 circular RNA in repressing glioma tumorigenesis. J Natl Cancer Inst. 2018;110:3.
- Klein M, Duffau H, De WHPC. Cognition and resective surgery for diffuse infiltrative glioma: an overview. J Neurooncol. 2012;108(2):309–318.
- Pessina F, Navarria P, Cozzi L, et al. Value of surgical resection in patients with newly diagnosed grade III glioma treated in a multimodal approach: surgery, chemotherapy and radiotherapy. Ann Surg Oncol. 2016;23(9):1–7.
- Reifenberger G, Weber T, Weber RG, et al. Chordoid glioma of the third ventricle: immunohistochemical and molecular genetic characterization of a novel tumor entity. Brain Pathol. 2010;9(4):617–626.
- Zhang SS, Lin YU. Research progress of MRI in glioma grading and molecular genetic biomarkers. Chin J Contemp Neurol Neurosurg. 2017;1:83–87.
- Gu G, Li W, Zhang J, et al. MicroRNA-384 inhibits proliferation migration and invasion of glioma by targeting at CDC42. Onco Targets Ther. 2018;11:4075–4085.
- Richards EJ, Zhang G, Li ZP, et al. Long non-CODING RNAs (LncRNA) regulated by transforming growth factor (TGF) β LncRNA-HIT-MEDIATED TGFβ-INDUCED EPITHELIAL TO MESENCHYMAL TRANSITION IN MAMMARY EPITHELIA. J Biol Chem. 2015b;290(11):6857.
- Xiong Y, Jia M, Yuan J, et al. STAT3-regulated long non-coding RNAs lnc-7SK and lnc-IGF2-AS promote hepatitis C virus replication. Mol Med Rep. 2015;12(5):6738.
- Goyal N, Kesharwani D, Datta M. Lnc-ing non-coding RNAs with metabolism and diabetes: roles of lncRNAs. Cell Mol Life Sci Cmls. 2018;75(Suppl):1.
- Kalmar A, Nagy ZB, Galamb O, et al. Abstract 165: common long noncoding RNAs (lncRNA) with altered expression levels in colorectal adenoma and carcinoma. Cancer Res. 2015;75(15 Supplement): 165–165.
- Richards EJ, Zhang G, Li ZP, et al. Long non-coding RNAs regulated by TGFβ: lncRNA-HIT mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia. J Biol Chem. 2015a;290(11):6857–6867.
- Cui Y, Yi L, Zhang MM, et al. WITHDRAWN: knockdown of LncRNA HOXA11 antisense promotes glioma cell apoptosis via sponging MiR-140-5p. Oncol Res. 2017. DOI:https://doi.org/10.3727/096504017X14972669062547
- Kiang MY, Zhang XQ, Leung KK. Long non-coding RNAs: the key players in glioma pathogenesis. Cancers (Basel). 2015;7(3):1406–1424.
- Atmadibrata B, Liu PY, Sokolowski N, et al. The novel long noncoding RNA linc00467 promotes cell survival but is down-regulated by N-Myc. Plos One. 2014;9(2):e88112.
- Guo S, Pridham K, Zhi S. Abstract A04: LINC00467 regulates the autophagy signaling pathway STK11/AMPK. Cancer Res. 2016;76(6 Supplement):A04–A04.
- Ke Z, Chi Z, Hui Y, et al. Knockdown of long non-coding RNA NEAT1 inhibits glioma cell migration and invasion via modulation of SOX2 targeted by miR-132. Mol Cancer. 2018;17(1):105.
- Amin M, Lam AK. Current perspectives of mi-RNA in oesophageal adenocarcinoma: roles in predicting carcinogenesis, progression and values in clinical management. Exp Mol Pathol. 2015;98(3):411–418.
- Ashraf NM, Imran K, Kastner DW, et al. Potential involvement of mi-RNA 574-3p in progression of prostate cancer: A bioinformatic study. Mol Cell Probes. 2017;36:21–28.
- Chakraborty C, Sharma AR, Sharma G, et al. Therapeutic miRNA and siRNA: moving from bench to clinic as next generation medicine. Mol Ther Nucleic Acids. 2017;8(C):132–143.
- Zeng Y, Wang KX, Xu H, et al. Integrative miRNA analysis identifies hsa‐miR‐3154, hsa‐miR‐7‐3, and hsa‐miR‐600 as potential prognostic biomarker for cervical cancer. J Cell Biochem. 2018;119:2.
- Dou Z, Lin S, Dai C, et al. Pooling-analysis for diagnostic and prognostic value of MiRNA-100 in various cancers. Oncotarget. 2017;8(37):62703–62715.
- Mollaie HR, Monavari SH, Arabzadeh SA, et al. RNAi and miRNA in viral infections and cancers. Asian Pac J Cancer Prev Apjcp. 2013;14(12):7045–7056.
- Uhlmann S, Zhang JD, Schwäger A, et al. miR-200bc/429 cluster targets PLCγ1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene. 2010;29(30):4297–4306.
- Wang B, Koh P, Winbanks C, et al. miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression. Diabetes. 2011;60(1):280–287.
- Zhu H, Zheng T, Yu J, et al. LncRNA XIST accelerates cervical cancer progression via upregulating Fus through competitively binding with miR-200a. Biomed Pharmacothe. 2018;105:789.
- Ye S, Yang L, Zhao X, et al. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer. Cell Biochem Biophys. 2014;70(3):1849–1858.
- Sang XB, Zong ZH, Wang LL, et al. E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C. Oncotarget. 2017;8(9):14777–14793.
- Kort EJ, Farber L, Tretiakova M, et al. The E2F3-oncomir-1 axis is activated in Wilms’ tumor. Cancer Res. 2008;68(11):4034–4038.
- Olsson AY, Feber A, Edwards S, et al. Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells. Oncogene. 2007;26(7):1028–1037.
- Guénin S, Mauriat M, Pelloux J, et al. Normalization of qRT-PCR data: the necessity of adopting a systematic, experimental conditions-specific, validation of references. J Exp Bot. 2009;60(2):487–493.
- Xu XY, Nie XC, Ma HY, et al. Flow cytometry method analysis of apoptosis: no significant difference between EDTA and EDTA-free trypsin treatment procedure. Technol Cancer Res Treat. 2015;14(2):237.
- Utermann G. Apolipoprotein E phenotyping from serum by Western blotting. Electrophoresis. 2010;7(11):492–495.
- Murthy V, Le H, Samaras D, et al. Center-focusing multi-task CNN with injected features for classification of glioma nuclear images. In IEEE Winter Conf Appl Comput Vis, vol. 1; 2017. pp. 834–841.
- Shi W, Cui X, Shi J, et al. Overcoming the blood–brain barrier for glioma-targeted therapy based on an interleukin-6 receptor-mediated micelle system. RSC Adv. 2017;7(44):27162–27169.
- Papagiannakopoulos T, Friedmannmorvinski D, Neveu P, et al. Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. Oncogene. 2012;31(15):1884.
- Honda N, Yagi K, Ding GR, et al. Radiosensitization by overexpression of the nonphosphorylation form of IκB-α in human glioma cells. J Radiat Res. 2018;43(3):283–292.
- Giladi M, Munster M, Schneiderman RS, et al. Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells. Radiat Oncol. 2017;12(1):206.
- Guan YX, Zhang ZM, Chen XZ, et al. Lnc RNA SNHG20 participated in proliferation, invasion and migration of breast cancer cells via miR-495. J Cell Biochem. 2018;119. DOI:https://doi.org/10.1002/jcb.26588
- Grote P, Wittler L, Hendrix D, et al. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev Cell. 2013;24(2):206–214.
- Wang W, Yang F, Zhang L, et al. LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas. Oncotarget. 2016;7(47):77225–77236.
- Hu L, Lv QL, Chen SH, et al. Up-regulation of long non-coding RNA ab073614 predicts a poor prognosis in patients with glioma. Int J Environ Res Public Health. 2016;13(4):433.
- Zhang S, Xiao J, Chai Y, et al. LncRNA-CCAT1 promotes migration, invasion, and EMT in intrahepatic cholangiocarcinoma through suppressing miR-152. Dig Dis Sci. 2017;62(11):1–9.
- Zhang G, Sun H, Zhang Y, et al. Characterization of dysregulated lncRNA-mRNA network based on ceRNA hypothesis to reveal the occurrence and recurrence of myocardial infarction. Cell Death Discov. 2018;4(1):35.
- Li N, Long B, Han W, et al. microRNAs: important regulators of stem cells. Stem Cell Res Ther. 2017;8(1):110.
- Ping Y, He X, Li X, et al. Identification of miR-128 and miR-21 in the cerebrospinal fluid as biomarker for the diagnosis of glioma. Int J Lab Med. 2014;18:46-47, 50.
- Eades G, Yao Y, Yang M, et al. miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells. J Biol Chem. 2011;286(29):25992–26002.
- Qin L, Yang Y, Liu Q, et al. IncRNA F630028O10Rik contributes to suppress lung cancer in mice through inhibiting miR-223-3p and VEGF signaling pathway. Chest. 2016;149(4):A304–A304.
- Wang L, Chen H, Wang C, et al. Negative regulator of E2F transcription factors links cell cycle checkpoint and DNA damage repair. Proc Natl Acad Sci U S A. 2018;115(16):201720094.